Automation in Immunohistochemistry: Enhancing Accuracy and Efficiency
Immunohistochemistry in Infectious Disease and Neurological Research
The Immunohistochemistry Market is not solely focused on oncology; it is also a powerful and growing tool in the diagnosis and research of infectious and neurological diseases. For infectious diseases, IHC is used to detect the presence of specific microbial or viral antigens within host tissues, providing a clear visual confirmation of an infection. This is particularly valuable in cases where traditional microbiological cultures are slow, difficult to perform, or yield ambiguous results. IHC can help identify pathogens like viruses, bacteria, and fungi, and is used to study the host-pathogen interaction, which is crucial for developing effective treatments and vaccines. The ability to localize the pathogen within the tissue context provides unique insights that are not possible with other molecular techniques.
Similarly, in neurological research and diagnostics, IHC plays a vital role in identifying specific protein aggregates and markers associated with neurodegenerative disorders such as Alzheimer's and Parkinson's disease. Pathologists use IHC to visualize protein plaques, such as amyloid-beta or tau, in brain tissue, which is essential for confirming a diagnosis and understanding disease progression. LSI keywords such as neuropathology, infectious agents, protein aggregates, and disease markers highlight these diverse applications. The increasing research into these complex diseases and the need for more specific and sensitive diagnostic tools are key drivers for the IHC market. This broadening scope beyond its traditional applications underscores the versatility and indispensable nature of the IHC technique in modern medicine.